An advisory panel to the Food and Drug Administration met on Thursday to review Moderna’s application for emergency use authorization for its COVID-19 vaccine. NPR discusses the latest.
FDA Immunization Panel Assesses Moderna’s Application For Its COVID-19 Vaccine
